Follow-up management of cases after surgical treatment of cervical cancer should be determined by the results of postoperative pathology. Those without lymph node metastasis but combined with the following high-risk factors: large primary tumor size with deep mesenchymal infiltration and/or lymphovascular interstitial infiltration need to be supplemented with pelvic radiotherapy (level 1 evidence) ± cisplatin concurrent chemotherapy (chemotherapy as level 2B evidence), and observation is also an option. 1. positive lymph nodes 2. positive cut margins 2. parametrial infiltration Postoperative supplemental pelvic radiotherapy + cisplatin concurrent chemotherapy (level 1 evidence) ± vaginal brachytherapy is required. For positive para-aortic lymph nodes, chest CT or PET is feasible. 1. If there are no other distant metastases, perform para-aortic lymph node radiotherapy + cisplatin concurrent chemotherapy + pelvic radiotherapy ± brachytherapy; 2. If combined with distant metastases, biopsy can be performed at the suspected site first. individualized radiotherapy.